Regenerative Medicine
Methylene Blue
Enhance mitochondrial function, sharpen cognition, and slow aging at the cellular level.
Methylene blue is one of the oldest pharmaceuticals in existence — and one of the most compelling emerging tools in longevity and cognitive medicine. It acts as a powerful mitochondrial electron carrier, improving cellular energy production (ATP) and protecting neurons from oxidative stress. Administered via IV at therapeutic doses, methylene blue offers rapid cognitive enhancement, neuroprotection, and anti-aging effects at the mitochondrial level.
Methylene blue is administered as a slow IV infusion at sub-therapeutic doses (0.5–4 mg/kg). The characteristic blue coloration of urine during treatment is expected and harmless. Our clinical team titrates dosing carefully based on individual response. Methylene blue has well-established safety data at therapeutic doses and a long history of FDA-approved medical use. Important contraindications: G6PD deficiency (absolute), serotonin syndrome risk when combined with SSRIs/SNRIs or MAOIs — a full medication review is conducted before every treatment. Methylene blue is not currently available for patients on serotonergic medications.
Key Benefits
Start here
Book now to talk through whether methylene blue is the right fit for your goals, timeline, and recovery plan.
Book now →Related Protocols